HM

Hemal Milan Desai

Director Whole-Time Director DIN 07014744
DIN 07014744 First appointment Oct 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemal Milan Desai

Data last updated:

Hemal Milan Desai was a Whole-Time Director at Gufic Biosciences Limited (2014–2020) and Director at Gufic Lifesciences Private Limited (from 2017). The companies operate in Pharma.

DIN 07014744
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 01 Oct 2014
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gufic Biosciences Limited L24100MH1984PLC033519
Whole-Time Director01 Oct 20141984₹823 Cr (FY 2025)Active
Gufic Lifesciences Private Limited U24230GJ2012PTC070990
Director29 May 20172012₹46.35 Cr (FY 2020)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Gufic Lifesciences Private Limited
Gufic Biosciences Limited
Premium access

Shareholding and investment profile for Hemal Milan Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemal Milan Desai

Hemal Milan Desai was first appointed on 01 Oct 2014 as Whole-Time Director at Gufic Biosciences Limited. The most recent appointment on record is 29 May 2017 at Gufic Lifesciences Private Limited.

Hemal Milan Desai held 2 earlier board appointments: Gufic Biosciences Limited (Whole-Time Director, 01 Oct 2014 to 01 Oct 2020); Gufic Lifesciences Private Limited (Director, from 29 May 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available